Investigating how HIV affects heart disease and inflammation
Role of Hematopoietic System and Proteomics in HIV-Associated CardiovascularDisease
This study is looking at how living with HIV can affect heart health, especially by exploring how long-term inflammation might increase the risk of heart disease, and it aims to find ways to help improve heart health for people with HIV.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-11138342 on NIH RePORTER |
What this research studies
This research focuses on understanding the relationship between HIV infection and cardiovascular disease (CVD). It aims to explore the mechanisms that contribute to increased heart disease risk in individuals living with HIV, particularly the role of chronic inflammation. The study will involve clinical trials and patient-oriented research to identify effective therapies that can reduce inflammation and improve heart health in this population. Patients may be monitored through advanced imaging techniques to assess their cardiovascular health in relation to HIV.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV who are at risk for cardiovascular disease.
Not a fit: Patients who do not have HIV or those with pre-existing severe cardiovascular conditions unrelated to HIV may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments and preventive strategies for heart disease in patients living with HIV.
How similar studies have performed: Previous research has shown promising results in understanding the link between HIV and cardiovascular disease, indicating that this approach has potential for significant advancements.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Hsue, Priscilla Y. — University of California Los Angeles
- Study coordinator: Hsue, Priscilla Y.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.